Focused Wealth Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
DTC
Focused Wealth Management's EDIT Position: Q1 2024 in Review
Focused Wealth Management sold out of Editas Medicine (EDIT) in Q1 2024, closing a stake of 2,827 shares — an estimated $28.6K sold.
Focused Wealth Management first reported a position in EDIT in Q3 2017 and held it in 26 quarters. The position peaked at $946K in Q2 2018. 225 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.
- Focused Wealth Management reported no remaining Editas Medicine position as of Q1 2024 after selling out during the quarter.
- Focused Wealth Management sold 2,827 Editas Medicine shares in Q1 2024, an estimated $28.6K.
- Focused Wealth Management first reported a position in Editas Medicine in Q3 2017 and held it in 26 quarters.
- Focused Wealth Management's Editas Medicine position peaked at $946K in Q2 2018.
- 225 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.
Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.